The Gallbladder Treatment Market is experiencing noteworthy trends as advancements in medical science and technology continue to shape the landscape of gallbladder-related disorders. One major trend is in the market that the minimally invasive surgical techniques are being quickly adopted by more and more consumers. This surgery is called Laparoscopic cholecystectomy. Due to many reasons, the surgery has become popular. For example, such benefits as lesser postoperative pain, shorter hospital stays, and faster recoveries have been documented. This trend marks a departure from more old-styled open surgical procedures, which encourages a greater patient population to take advantage of the benefits of faster recovery.
While surgical measures are the primary choices in tackling this problem, researchers have now ventured into other alternatives that do not involve surgery. There is a focus on conservative methods of doing it which include things like, taking oral medication to dissolve gallstones or shock wave therapy to fragment them and break them into smaller pieces. This movement is in line with the decision to give patients the chance to avoid the surgery which may not be necessary, particularly, the case of asymptomatic stones or patients with higher surgical risk.
Moreover, endoscopic techniques in gallbladder treatment are constantly also experiencing the phase of advancements. According to the latest statistics, ERCP and EUS are among the most frequent diagnostic and therapeutic tools for gallbladder and biliary tract pathologies. These well-established and less invasive endoscopic methods have the dual purpose of both diagnostic and therapeutic intervention at the same time, which you couldn’t before because of the limited scope of interventions available.
The consumer-driven market is also going towards the personalized and precision medicine applications. Cutting-edge developments like genetic testing and molecular profiling are making it possible for healthcare providers to practice precision medicine by giving treatment plans based on individual patient's characteristics. This trend falls under a common umbrella of prevention, which is a result of the current health care shift to more individualized and situated methods of treatment that are aimed towards achieving an improved outcome side effect
The market additionally goes up with the new trend in the use of sophisticated imaging technologies for the purpose of gallbladder diagnosis and surveillance. Magnetic resonance cholangiopancreatography (MRCP) and computed tomography (CT) scan permits visualization of inner composition of the gallbladder and neighbour in detail matter helping in timely and accurate diagnosis and treatment planning. This phenomenon also shows that the correct diagnosis of the gallbladder pave the way for the treatment given in the cholelithiasis.
Moreover, patient education and awareness campaigns have been seen as a major market driving factor during the recent years in the gallbladder treatment market. Attempts designed to impart people with information concerning gallbladder disorders and the symptoms and associated with them will result in the early diagnosis and intervention. It suggests that apart from being reactive in illnesses, this behavior includes proactive healthcare seeking and making informed healthcare decisions.
In addition, there is a wide emphasis on being preventive for gallbladder related issues. Lifestyle modifications, including a balanced diet, regular exercise, and weight management, are being promoted to reduce the risk of gallstones and other gallbladder-related issues. This trend reflects a proactive approach to healthcare, encouraging individuals to adopt habits that can contribute to the prevention of gallbladder disorders.
The Gall bladder Treatment Market is projected to reach USD 28,563.7 Million by 2030 at 8.3% CAGR during the forecast period 2022-2030.The gall bladder is a small pear-shaped located underneath the liver. Its main function is to store the bile produced by liver and pass it along through a duct that empties into the small intestine. Gall bladder diseases affect a large number of people in the world. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013 and they resulted in 106,000 deaths. The major driving factors for the growth of the market are increasing geriatric population, increasing prevalence rate of various gallbladder diseases, and introduction & adoption of advanced diagnostic treatment options. Moreover, increasing awareness of the diseases, rising healthcare expenditure, and rising demand from emerging markets of Asia have fuelled the market growth. However, pain and complications during surgery and asymptomatic nature of gallstones may slow the growth of the market.
Figure- Global gall bladder treatment market, by diseases indication (2016) (%)
Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Key Findings
Intended Audience
Research Methodology
 Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Â
Segments Â
Global gall bladder treatment market has been segmented on the basis of disease indications, diagnosis, treatment and end users. On the basis of disease indications the market is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer. On the basis of diagnosis the market is categorized as ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy and others. On the basis of treatment the market is segmented into surgery, and drugs and on the basis of end users the market is divided into hospitals & gynecology clinics, academic & research centers and others.
Regional analysis   Â
Considering the global scenario of the market, North America dominates the global gall bladder treatment market owing to the presence of huge population suffering from gall bladder diseases. US holds the largest market share in North America gall bladder treatment market. In developed countries, 10–15% of adults have gallstones. Europe has the second largest market for the gall bladder treatment which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the gall bladder treatment market in Europe is growing at a CAGR of 6.8%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge population, rising healthcare expenditure and government support for research & development. Asia Pacific gall bladder treatment market is expected to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa is expected to have limited growth.
Key players for global gall bladder treatment market  Â
Some of the major players in this market are: Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others The report for Global Gall Bladder Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)